Shapiro David
Chief Medical Officer at INTERCEPT PHARMACEUTICALS INC
- Sold, on record
- $37.1M
- Dollars the filings state
- Form 4 sales
- 68
- Latest May 1, 2019
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- INTERCEPT PHARMACEUTICALS INCChief Medical Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not statedDec 17, 2018 2018
Sold 2,000 shares at $106.62 ($213k)
Shapiro David, Chief Medical Officer
Sold 4.9% of holdings ($4.4M position)39,152 shares left1.8x usual sizeFiling
- 2 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not statedJan 3, 2019 +17 days
Sold 2,699 shares at $98.07 ($265k)
Shapiro David, Chief Medical Officer
Sold 6.7% of holdings ($4M position)37,717 shares left2.4x usual sizeFiling
- 3 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not statedJan 4, 2019 +1 day
Sold 474 shares at $97.48 ($46k)
Shapiro David, Chief Medical Officer
Sold 1.3% of holdings ($3.7M position)37,243 shares left0.4x usual sizeFiling
- 4 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not statedFeb 15, 2019 +42 days
Sold 2,000 shares at $111.51 ($223k)
Shapiro David, Chief Medical Officer
Sold 4.7% of holdings ($4.7M position)40,543 shares left1.8x usual sizeFiling
- 5 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not statedMar 1, 2019 +14 days
Sold 2,000 shares at $103.16 ($206k)
Shapiro David, Chief Medical Officer
Sold 4.7% of holdings ($4.4M position)40,543 shares left1.8x usual sizeFiling
- 6 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not statedApr 3, 2019 +33 days
Sold 562 shares at $115.01 ($65k)
Shapiro David, Chief Medical Officer
Sold 1.4% of holdings ($4.6M position)39,499 shares left0.5x usual sizeFiling
- 7 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not statedApr 15, 2019 +12 days
Sold 2,000 shares at $95.00 ($190k)
Shapiro David, Chief Medical Officer
Sold 4.8% of holdings ($3.9M position)39,499 shares left1.7x usual sizeFiling
- 8 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not statedMay 1, 2019 +16 days
Sold 2,000 shares at $86.28 ($173k)
Shapiro David, Chief Medical Officer
Sold 4.8% of holdings ($3.6M position)39,499 shares left1.6x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (68)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 1, 2019 | May 3, 2019 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 2,000 | $173k | 4.8% | Plan not stated | SEC |
| Apr 15, 2019 | Apr 16, 2019 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 2,000 | $190k | 4.8% | Plan not stated | SEC |
| Apr 3, 2019 | Apr 3, 2019 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 562 | $65k | 1.4% | Plan not stated | SEC |
| Mar 1, 2019 | Mar 1, 2019 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 2,000 | $206k | 4.7% | Plan not stated | SEC |
| Feb 15, 2019 | Feb 20, 2019 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 2,000 | $223k | 4.7% | Plan not stated | SEC |
| Jan 4, 2019 | Jan 4, 2019 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 474 | $46k | 1.3% | Plan not stated | SEC |
| Jan 3, 2019 | Jan 3, 2019 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 2,699 | $265k | 6.7% | Plan not stated | SEC |
| Dec 17, 2018 | Dec 19, 2018 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 2,000 | $213k | 4.9% | Plan not stated | SEC |
| Nov 1, 2018 | Nov 2, 2018 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 2,000 | $193k | 4.9% | Plan not stated | SEC |
| Oct 15, 2018 | Oct 16, 2018 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 3,425 | $353k | 8.0% | Unusual | SEC |
| Oct 5, 2018 | Oct 5, 2018 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 759 | $84k | 1.9% | Plan not stated | SEC |
| Sep 5, 2018 | Sep 7, 2018 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 4,917 | $548k | 10.4% | Unusual | SEC |
| Oct 2, 2017 | Oct 4, 2017 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 349 | $21k | 0.8% | Plan not stated | SEC |
| Sep 1, 2017 | Sep 5, 2017 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 1,250 | $147k | 2.7% | Plan not stated | SEC |
| Aug 1, 2017 | Aug 2, 2017 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 1,118 | $133k | 2.4% | Plan not stated | SEC |
| Jul 11, 2017 | Jul 13, 2017 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 553 | $69k | 1.2% | Plan not stated | SEC |
| Jul 3, 2017 | Jul 5, 2017 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 350 | $42k | 0.8% | Plan not stated | SEC |
| May 1, 2017 | May 3, 2017 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 1,117 | $125k | 2.4% | Plan not stated | SEC |
| Apr 10, 2017 | Apr 11, 2017 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 558 | $61k | 1.2% | Plan not stated | SEC |
| Apr 3, 2017 | Apr 5, 2017 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 346 | $40k | 0.7% | Plan not stated | SEC |
| Mar 1, 2017 | Mar 3, 2017 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 1,350 | $174k | 2.8% | Plan not stated | SEC |
| Jan 9, 2017 | Jan 11, 2017 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 1,565 | $166k | 3.7% | Plan not stated | SEC |
| Jan 3, 2017 | Jan 5, 2017 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 988 | $103k | 2.3% | Plan not stated | SEC |
| Dec 2, 2016 | Dec 6, 2016 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 1,350 | $135k | 3.0% | Plan not stated | SEC |
| Oct 10, 2016 | Oct 12, 2016 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 411 | $63k | 0.9% | Plan not stated | SEC |
| Oct 3, 2016 | Oct 5, 2016 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 1,513 | $247k | 3.3% | Plan not stated | SEC |
| Sep 26, 2016 | Sep 28, 2016 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 3,545 | $585k | 7.3% | Plan not stated | SEC |
| Jul 5, 2016 | Jul 7, 2016 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 163 | $24k | 0.3% | Plan not stated | SEC |
| Apr 4, 2016 | Apr 6, 2016 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 165 | $22k | 0.3% | Plan not stated | SEC |
| Jan 4, 2016 | Jan 5, 2016 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 533 | $78k | 1.3% | Plan not stated | SEC |
| Dec 15, 2015 | Dec 17, 2015 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 3,500 | $551k | 11.0% | Plan not stated | SEC |
| Nov 16, 2015 | Nov 18, 2015 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 4,264 | $761k | 13.1% | Plan not stated | SEC |
| Nov 10, 2015 | Nov 12, 2015 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 3,500 | $715k | 10.7% | Plan not stated | SEC |
| Oct 2, 2015 | Oct 5, 2015 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 1,140 | $183k | 3.8% | Plan not stated | SEC |
| Sep 15, 2015 | Sep 17, 2015 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 3,500 | $669k | 13.0% | Plan not stated | SEC |
| Aug 17, 2015 | Aug 19, 2015 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 4,272 | $894k | 19.0% | Plan not stated | SEC |
| Jul 2, 2015 | Jul 7, 2015 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 851 | $201k | 4.3% | Plan not stated | SEC |
| Jul 1, 2015 | Jul 6, 2015 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 3,781 | $902k | 17.2% | Plan not stated | SEC |
| Jun 15, 2015 | Jun 17, 2015 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 3,500 | $846k | 15.9% | Plan not stated | SEC |
| May 15, 2015 | May 19, 2015 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 4,279 | $1.3M | 18.8% | Plan not stated | SEC |
| Apr 2, 2015 | Apr 3, 2015 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 3,459 | $952k | 15.2% | Plan not stated | SEC |
| Mar 16, 2015 | Mar 18, 2015 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 3,500 | $1M | 15.7% | Plan not stated | SEC |
| Mar 12, 2015 | Mar 16, 2015 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 5,000 | $1.4M | 21.0% | Plan not stated | SEC |
| Feb 17, 2015 | Feb 19, 2015 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 4,646 | $973k | 19.8% | Plan not stated | SEC |
| Jan 30, 2015 | Feb 3, 2015 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 7,500 | $1.5M | 33.9% | Unusual | SEC |
| Jan 5, 2015 | Jan 7, 2015 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 664 | $115k | 4.3% | Plan not stated | SEC |
| Jan 2, 2015 | Jan 5, 2015 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 376 | $60k | 2.4% | Plan not stated | SEC |
| Nov 17, 2014 | Nov 19, 2014 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 4,790 | $761k | 25.4% | Unusual | SEC |
| Oct 2, 2014 | Oct 3, 2014 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 5,020 | $1.2M | 25.3% | Unusual | SEC |
| Sep 15, 2014 | Sep 17, 2014 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 4,000 | $1.1M | 21.9% | Plan not stated | SEC |
| Aug 27, 2014 | Aug 29, 2014 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 10,000 | $2.9M | 41.2% | Unusual | SEC |
| Aug 15, 2014 | Aug 15, 2014 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 4,774 | $1.4M | 25.1% | Unusual | SEC |
| Jul 2, 2014 | Jul 3, 2014 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 5,036 | $1.2M | 25.1% | Unusual | SEC |
| Jun 16, 2014 | Jun 18, 2014 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 4,000 | $1.1M | 21.7% | Plan not stated | SEC |
| May 15, 2014 | May 19, 2014 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 4,743 | $1.3M | 24.7% | Plan not stated | SEC |
| Apr 2, 2014 | Apr 3, 2014 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 5,393 | $1.8M | 28.3% | Unusual | SEC |
| Mar 17, 2014 | Mar 19, 2014 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 4,456 | $1.9M | 25.3% | Unusual | SEC |
| Feb 14, 2014 | Feb 18, 2014 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 5,772 | $2.1M | 44.4% | Unusual | SEC |
| Jan 8, 2014 | Jan 10, 2014 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 4,928 | $354k | 36.3% | Unusual | SEC |
| Dec 16, 2013 | Dec 17, 2013 | INTERCEPT PHARMACEUTICALS INC | CMO & EVP - Development | Form 4 sale | 5,016 | $312k | 62.6% | Unusual | SEC |
| Nov 15, 2013 | Nov 19, 2013 | INTERCEPT PHARMACEUTICALS INC | CMO & EVP - Development | Form 4 sale | 4,730 | $227k | 52.6% | Unusual | SEC |
| Oct 2, 2013 | Oct 3, 2013 | INTERCEPT PHARMACEUTICALS INC | CMO & EVP - Development | Form 4 sale | 4,392 | $320k | 45.6% | Unusual | SEC |
| Aug 16, 2013 | Sep 18, 2013 | INTERCEPT PHARMACEUTICALS INC | CMO & EVP - Development | Form 4 sale | 5,016 | $247k | 54.0% | Unusual | SEC |
| Aug 15, 2013 | Aug 16, 2013 | INTERCEPT PHARMACEUTICALS INC | CMO & EVP - Development | Form 4 sale | 4,754 | $214k | 65.2% | Unusual | SEC |
| Jul 2, 2013 | Jul 3, 2013 | INTERCEPT PHARMACEUTICALS INC | CMO & EVP - Development | Form 4 sale | 4,369 | $191k | 55.3% | Unusual | SEC |
| Jun 17, 2013 | Jun 19, 2013 | INTERCEPT PHARMACEUTICALS INC | CMO & EVP - Development | Form 4 sale | 5,016 | $164k | 66.5% | Unusual | SEC |
| May 16, 2013 | May 20, 2013 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 5,016 | $157k | 56.9% | Unusual | SEC |
| Apr 9, 2013 | Apr 11, 2013 | INTERCEPT PHARMACEUTICALS INC | CMO and EVP - Development | Form 4 sale | 3,750 | $129k | 100.0% | Unusual | SEC |